Equillium News

We're Keeping An Eye On Equillium's (NASDAQ:EQ) Cash Burn Rate

Yahoo Finance06:04 ET

Short Interest on Energy Stocks up in March; APA and EQT Most Shorted, COP Least Shorted

Seeking AlphaApr 15 12:11 ET

Investors Don't See Light At End Of Equillium, Inc.'s (NASDAQ:EQ) Tunnel And Push Stock Down 28%

The Equillium, Inc. (NASDAQ:EQ) share price has softened a substantial 28% over the previous 30 days, handing back much of the gains the stock has made lately. Of course, over the longer-term many

Simply Wall StApr 9 06:00 ET

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Equillium, Inc. (NASDAQ:EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that on April 1, 2024, the Compensation

BusinesswireApr 3 08:00 ET

Buy Rating Affirmed for Equillium on Strong Clinical Data and Potential Financial Upsides

TipRanksApr 3 01:45 ET

Equillium Is Maintained at Buy by HC Wainwright & Co.

Equillium Is Maintained at Buy by HC Wainwright & Co.

Dow JonesApr 2 09:06 ET

Express News | HC Wainwright & Co. Maintains Buy on Equillium, Raises Price Target to $5

Moomoo 24/7Apr 2 08:55 ET

Equillium Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/02/2024 138.1% HC Wainwright & Co. $4 → $5 Maintains Buy 12/26/2023 90.48% HC Wainwright & Co. $4.5 → $

BenzingaApr 2 08:54 ET

Buy Rating Reaffirmed for Equillium on Strong Itolizumab Trial Results and Positive Financial Outlook

TipRanksApr 2 06:27 ET

Equillium Announces Positive Topline Data From the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis

Topline data delivered to Ono Pharmaceutical, representing the first of two data sets that will trigger Ono's option exercise decision for itolizumabItolizumab continues to show clinically meaningful

BusinesswireApr 1 08:00 ET

Buy Rating Affirmed for Equillium Amid Promising Clinical Trials and Potential Financial Upsides

TipRanksMar 27 02:55 ET

Equillium Shares Fall After Swing to 4Q Loss

By Dean Seal Shares of Equillium fell after the company swung to a loss in the fourth quarter on lower sales. The stock was down 18% at $2 on Tuesday. Shares have more than doubled since the start o

WSJMar 26 13:57 ET

12 Health Care Stocks Moving In Tuesday's Intraday Session

GainersStoke Therapeutics (NASDAQ:STOK) stock moved upwards by 71.8% to $11.16 during Tuesday's regular session. The company's market cap stands at $498.5 million. The company's, Q4 earnings came out

BenzingaMar 26 13:31 ET

VERI, CHEK and CZOO Among Mid-day Movers

Seeking AlphaMar 26 12:55 ET

Express News | Equillium Shares Are Trading Lower. The Company Reported Q4 Financial Results

Moomoo 24/7Mar 26 12:11 ET

Equillium: Q4 Earnings Insights

Equillium (NASDAQ:EQ) reported its Q4 earnings results on Monday, March 25, 2024 at 04:01 PM.Here's what investors need to know about the announcement.EarningsEquillium beat estimated earnings by 59.0

BenzingaMar 25 17:35 ET

Equillium Swings to Q4 Loss As Revenue Falls

Equillium (EQ) reported a Q4 loss late Monday of $0.07 per diluted share, compared with net income of $0.08 a year earlier. Three analysts polled by Capital IQ expected a loss of $0.17. Revenue for th

MT NewswiresMar 25 16:26 ET

Express News | Equillium Q4 2023 GAAP EPS $(0.07) Beats $(0.17) Estimate, Sales $9.200M Beat $6.425M Estimate

Moomoo 24/7Mar 25 16:02 ET

Earnings Flash (EQ) EQUILLIUM Reports Q4 Revenue $9.2M

04:02 PM EDT, 03/25/2024 (MT Newswires) -- Earnings Flash (EQ) EQUILLIUM Reports Q4 Revenue $9.2M

MT NewswiresMar 25 16:02 ET

Equillium 4Q Loss $2.34M >EQ

Equillium 4Q Loss $2.34M >EQ

Dow JonesMar 25 16:01 ET